Pharma Partnerships Expand Equity Initiatives

Evaluating the Risk of Nitrosamines: Zantac's 4-Year-Old Recall Is Still Affecting Industry.

Keeping Pace in the Health Tech Space, Verily Nails $1B Investment Round

Pioneer in Castleman's Disease Launches Nonprofit Drug Repurposing Organization

Increased contraceptive education can help manage impact of Roe vs. Wade

FDA Accelerated Approval Expands Enhertu Indication to NSCLC

CVS' Primary Care Venture Treads On Providers, Pharma

Paxlovid rebound raises questions, but studies have answers

Monkeypox Vaccine Puts Bavarian Nordic on the Spot

Neuraxpharm Will Buy Sanofi CNS Portfolios

Pages